Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | SNV1521 |
| Synonyms | |
| Therapy Description |
SNV1521 selectively inhibits PARP1, potentially resulting in decreased tumor growth (Cancer Res (2025) 85 (8_Supplement_1): 5725). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| SNV1521 | SNV-1521|SNV 1521 | PARP-1 Inhibitor 13 | SNV1521 selectively inhibits PARP1, potentially resulting in decreased tumor growth (Cancer Res (2025) 85 (8_Supplement_1): 5725). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06220864 | Phase I | SNV1521 | SNV1521 in Participants With Advanced Solid Tumors | Recruiting | USA | AUS | 0 |